PDS BIOTECHNOLOGY CORPORATION PDSB 深 沪
等待开盘 08-02 09:30:00 美东时间
1.09
+0.020
+1.87%
华盛通- 最 高1.09
- 今 开1.08
- 成交量 22.19万股
- 最 低 1.02
- 昨 收 1.07
- 总市值 4982.39万
- 52周最高 4.29
- 市盈率 静 --
- 换手率 0.49%
- 52周最低 0.8505
- 委 比 -64.58%
- 总股本 4571.00万
- 历史最高 17.85
- 量 比 0.70
- 振 幅 6.54%
- 历史最低 0.615
- 每 手 1
- 风险率 1.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多RBC Capital Maintains Outperform on Precision Drilling, Raises Price Target to $100
RBC Capital analyst Keith Mackey maintains Precision Drilling (NYSE:PDS) with a Outperform and raises the price target from $89 to $100.
08-01 00:45
Precision Drilling Q2 EPS $0.77 and Sales $293.753M
Precision Drilling (NYSE:PDS) reported quarterly earnings of $0.77 per share. This is a 26.67 percent decrease over earnings of $1.05 per share from the same period last year. The company reported quarterly sales of
07-30 14:49
Earnings Scheduled For July 29, 2025
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is projected to repor...
07-29 16:32
Precision Drilling Q2 2025 Earnings Preview
Precision Drilling (NYSE:PDS) is scheduled to announce Q2 earnings results on Tuesday, July 29th, after market close. The consensus EPS Estimate is $0.04 and the consensus Revenue Estimate is $289.44M...
07-29 05:35
Nuclear Energy Newcomers Electrify Final Day of EnerCom's 30th Anniversary Energy Investment Conference
Five Nuclear Companies to Present at EnerCom Denver – The Energy Investment Conference Qualified Investors, Analysts and Energy Industry Professionals Can Register at No Cost at www.enercom...
07-24 03:14
PDS Biotechnology Completes Recruitment for Clinical Trial
PDS Biotechnology ( ($PDSB) ) has issued an announcement. On July 10, 2025, PDS...
07-10 20:27
PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results
PDS Biotechnology Corporation announced the completion of patient enrollment in Stage 1 of a clinical trial for PDS01ADC in combination with floxuridine for metastatic colorectal cancer patients. The trial, led by the National Cancer Institute, met pre-set RECIST v1.1 criteria, advancing the colorectal cancer cohort to Stage 2. PDS01ADC is an IL-12 fused antibody drug conjugate targeting tumor necrosis regions. The trial also includes cohorts for...
07-10 12:00
GENMA品牌获东南亚市场4台混合动力轮胎吊新订单
近日，GENMA与东南亚知名集装箱码头运营商正式签约4台电池混合动力轮胎吊。此次合作是GENMA与该东南亚客户的首次携手，标志着GENMA在东南亚港口机械市场再...
07-03 21:54
ICDIA 2025 高峰论坛嘉宾前瞻全揭秘，“芯”风向抢先看！
（转自：SIP集成电路） ICDIA 2025 创芯展 上午场 尹首一 清华大学集成电路学院 副院长 嘉宾简介 尹首一...
07-01 17:21
美股大行评级 | GitLab遭多家大行下调目标价！Stifel首予优步"买入"评级，目标价110美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139839943846023169.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Loop Capital：维持Dave & Buster's Enter(PLAY)"买入"评级，目标价从35美元升至46美元</p> <p>• Stifel：维持嘉年华(CCL)"买入"评级，目标价从31美元升至
06-12 09:46
